Cardiome Pharma (CRME) Reports a Q1 Loss
More News related to CRME
- Cardiome Pharma (CRME) Reports a Q1 Loss
- Cardiome Reports Third Quarter Results
- Cardiome to Release Third Quarter Results
- Cardiome To Present At Oppenheimer Healthcare Conference
- Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial
Cardiome Pharma Corp. (NASDAQ: CRME) reports a Q1 loss of $0.01 vs. consensus of $0.17 profit. Revenues were $21.1 million vs. $26.78 million consensus.
Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
[SM]
Related Categories
EarningsStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
